Khalid Matalka
Directeur Technique/Scientifique/R&D chez QUANTA
Profil
Khalid Matalka is currently the Chief Scientific Officer at Quanta, Inc. He is also a Member at the American Association for Cancer Research.
Matalka holds a doctorate degree from The Ohio State University, an undergraduate degree from Yarmouk University, and a graduate degree from the University of Wisconsin-Milwaukee.
Postes actifs de Khalid Matalka
| Sociétés | Poste | Début |
|---|---|---|
| QUANTA | Directeur Technique/Scientifique/R&D | 01/02/2021 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01/01/1994 |
Formation de Khalid Matalka
| Yarmouk University | Undergraduate Degree |
| University of Wisconsin-Milwaukee | Graduate Degree |
| The Ohio State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Quanta, Inc.
 Quanta, Inc. Computer PeripheralsElectronic Technology Quanta, Inc. operates as an applied science company. It engages in the provision of a technology platform which focuses on increasing energy levels in plant matter to increase performance within the human body. The company was founded by Eric Allen Rice on April 28, 2016 and is headquartered in Burbank, CA. | Electronic Technology |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
